Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 2
1978 2
1982 3
1983 1
1984 2
1985 2
1986 2
1987 2
1988 1
1990 3
1991 1
1993 1
1994 2
1995 3
1996 2
1997 4
1998 4
1999 3
2001 6
2002 1
2003 3
2005 2
2006 1
2008 1
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C. Abifadel M, et al. Among authors: beucler i. Nat Genet. 2003 Jun;34(2):154-6. doi: 10.1038/ng1161. Nat Genet. 2003. PMID: 12730697
[Metabolism of atherogenic lipoproteins].
Beucler I, Turpin G. Beucler I, et al. Ann Med Interne (Paris). 2001 Apr;152(3):158-61. Ann Med Interne (Paris). 2001. PMID: 11431574 Review. French.
Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.
Sich D, Saïdi Y, Giral P, Lagrost L, Dallongeville J, Federspiel MC, Cherfils C, Raisonnier A, Turpin G, Beucler I. Sich D, et al. Among authors: beucler i. Atherosclerosis. 1998 Jun;138(2):351-60. doi: 10.1016/s0021-9150(98)00030-6. Atherosclerosis. 1998. PMID: 9690919
[Pathology of the human apolipoprotein E gene].
Iron A, Richard P, Beucler I, Thomas G, Pascual de Zulueta M, Bereziat G, Cassaigne A, de Gennes JL. Iron A, et al. Among authors: beucler i. Bull Acad Natl Med. 1994 Mar;178(3):415-26. Bull Acad Natl Med. 1994. PMID: 8076181 Review. French.
[Immunological assay of apolipoprotein A-I].
Ayrault-Jarrier M, Bobilewicz D, Pastier D, Beucler I, Polonovski J. Ayrault-Jarrier M, et al. Among authors: beucler i. Ann Biol Clin (Paris). 1982;40(3):187-94. Ann Biol Clin (Paris). 1982. PMID: 6814305 French.
APOE: a potential marker of disease progression in ALS.
Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat PF, Bruckert E, Meininger V. Lacomblez L, et al. Among authors: beucler i. Neurology. 2002 Apr 9;58(7):1112-4. doi: 10.1212/wnl.58.7.1112. Neurology. 2002. PMID: 11940705
58 results